Literature DB >> 26835031

Relevance of Monitoring Atrial Fibrillation in Clinical Practice.

Thorsten Lewalter1, Giuseppe Boriani2.   

Abstract

The monitoring of atrial fibrillation (AF) is performed using a variety of tools, ranging from the conventional Holter electrocardiogram to modern implantable loop recording with remote data exchange. The main clinical areas in AF where monitoring is crucial for decision-making are catheter and surgical ablation, as well as anticoagulation to prevent strokes. Identifying the patient cohort at risk - e.g., those with subclinical silent AF - is a challenge. In addition, the interaction of AF with implanted devices - e.g. AF-triggered inadequate shock therapy - should be the object of continuous monitoring. The prevention of inadequate shock delivery in particular is of major clinical importance.

Entities:  

Keywords:  Atrial fibrillation; implantable cardiac monitor; implantable cardioverter defibrillator; pacemaker; remote monitoring; rhythm monitoring

Year:  2012        PMID: 26835031      PMCID: PMC4711515          DOI: 10.15420/aer.2012.1.1.54

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN: 2050-3369


  59 in total

1.  Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study.

Authors:  Evgeny Pokushalov; Alexander Romanov; Giorgio Corbucci; Sergey Artyomenko; Alex Turov; Natalya Shirokova; Alexander Karaskov
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-09-19

2.  Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators.

Authors:  Ilan Goldenberg; Arthur J Moss; Scott McNitt; Wojciech Zareba; James P Daubert; W Jackson Hall; Mark L Andrews
Journal:  J Cardiovasc Electrophysiol       Date:  2006-06-06

3.  Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.

Authors:  Robby Nieuwlaat; Alessandro Capucci; Gregory Y H Lip; S Bertil Olsson; Martin H Prins; Fred H Nieman; José López-Sendón; Panos E Vardas; Etienne Aliot; Massimo Santini; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2006-05-26       Impact factor: 29.983

4.  Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

Authors:  Peter Alter; Stefan Waldhans; Eveline Plachta; Rainer Moosdorf; Wolfram Grimm
Journal:  Pacing Clin Electrophysiol       Date:  2005-09       Impact factor: 1.976

5.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation.

Authors:  Gaetano Senatore; Giuseppe Stabile; Emanuele Bertaglia; Giovanni Donnici; Antonio De Simone; Franco Zoppo; Pietro Turco; Pietro Pascotto; Massimo Fazzari
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

6.  Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation.

Authors:  Christopher Piorkowski; Hans Kottkamp; Hildegard Tanner; Richard Kobza; Jens Cosedis Nielsen; Arash Arya; Gerhard Hindricks
Journal:  J Cardiovasc Electrophysiol       Date:  2005-12

7.  Is ambulatory electrocardiography useful in the evaluation of patients with recent stroke?

Authors:  D K Kessler; K M Kessler
Journal:  Chest       Date:  1995-04       Impact factor: 9.410

8.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

9.  Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter.

Authors:  Frédéric Roche; Jean-Michel Gaspoz; Antoine Da Costa; Karl Isaaz; David Duverney; Vincent Pichot; Frédéric Costes; Jean-René Lacour; Jean-Claude Barthélémy
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

10.  Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.

Authors:  Robby Nieuwlaat; S Bertil Olsson; Gregory Y H Lip; A John Camm; Günter Breithardt; Alessandro Capucci; Joan G Meeder; Martin H Prins; Samuel Lévy; Harry J G M Crijns
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

View more
  1 in total

1.  Continuous monitoring after atrial fibrillation ablation: the LINQ AF study.

Authors:  Simon Wechselberger; Mads Kronborg; Yan Huo; Judith Piorkowski; Sebastian Neudeck; Ellen Päßler; Ali El-Armouche; Utz Richter; Julia Mayer; Stefan Ulbrich; Liying Pu; Bettina Kirstein; Thomas Gaspar; Christopher Piorkowski
Journal:  Europace       Date:  2018-11-01       Impact factor: 5.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.